Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chapdelaine
Albert H. Chapdelaine, Naperville, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100104518 | CHEWING GUM, CONFECTION, AND OTHER ORAL DELIVERY VEHICLES CONTAINING A TRADITIONAL CHINESE MEDICINE OR EXTRACT THEREOF - A method for producing a chewing gum with a controlled release traditional Chinese medicine active agent, as well as the chewing gum so produced, is obtained by physically modifying the release properties of the traditional Chinese medicine active agent by coating and drying. The traditional Chinese medicine active agent is coated by encapsulation, partially coated by agglomeration, entrapped by absorption, or treated by multiple steps of encapsulation, agglomeration, and absorption. The coated traditional Chinese medicine active agent is preferably then co-dried and particle sized to produce a release-modified traditional Chinese medicine active agent for use in chewing gum. The traditional Chinese medicine active agent may also be used in a coating on a chewing gum product, as part of a rolling compound applied to the chewing gum product, or as a part of the liquid in a liquid-center chewing gum product. | 04-29-2010 |
Alcide Chapdelaine, Ile Des Soeurs CA
| Patent application number | Description | Published |
|---|---|---|
| 20090011985 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 01-08-2009 |
| 20090253623 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 10-08-2009 |
| 20100087366 | GH SECRETAGOGUES AND USES THEREOF - The invention relates to use of a GH secretagogue (e.g. GRF or an analog thereof) for (1) altering a lipid parameter in a subject; (2) altering a body composition parameter in a subject, (3) treating a condition characterized by deficient or decreased bone formation in a subject (4) improving daytime vigilance and/or cognitive function in a subject, (5) improving a metabolic condition in a subject, (6) improving anabolism in a catabolic condition in a subject, and/or (7) improving and/or reconstituting immune function in a subject. | 04-08-2010 |
Benoit Chapdelaine, St-Denis De Brompton CA
| Patent application number | Description | Published |
|---|---|---|
| 20090241822 | PERSONAL WATERCRAFT BALLAST - A personal watercraft has a hull and a deck. The deck includes a pedestal, two gunnels, two footrests, and a rear platform. A straddle-type seat is disposed on the pedestal. A steering assembly is disposed at least in part forwardly of the seat. An engine is supported by the hull. A propulsion system is connected to the hull and is operatively connected to the engine. A ballast tank is disposed at least in part on the rear platform. The ballast tank includes a rigid ballast tank body, and at least two apertures in the ballast tank body. A connector releasably connects the ballast tank to one of the hull and the deck. A pump fluidly communicates with one of the at least two apertures in the ballast tank body. A ballast tank having a generally L-shaped rigid ballast tank body is also disclosed. | 10-01-2009 |
Claude Chapdelaine, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20090273711 | METHOD AND APPARATUS FOR CAPTION PRODUCTION - A method for determining a location of a caption in a video signal associated with a Region Of Interest (ROI), such as a face or text, or an area of high motion activity. The video signal is processed to generate ROI location information, the ROI location information conveying the position of the ROI in at least one video frame. The position where a caption can be located within one or more frames of the video signal is then determined on the basis of the ROI location information. This is done by identifying at least two possible positions for the caption in the frame such that the placement of the caption in either one of the two positions will not mask the ROI. A selection is then made among the at least two possible positions. The position picked is the one that would typically be the closest to the ROI such as to create a visual association between the caption and the ROI. | 11-05-2009 |
Claude J. Chapdelaine, Leominster, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100270235 | BOUYANT WATER HEATING DEVICE - A buoyant water heating device that may be used in a natural setting, such as a pond or lake, or in a man-made water-containing apparatus, such as a pool or water-treatment lagoon. The device comprises a water-filled, generally cylindrical anchor member coupled to a hollow, generally annular base member, and may he used alone or in combination with multiple other devices to create a free-floating blanket on the surface of the water. The device absorbs solar energy to heat water external to the device, and also provides a layer of thermal insulation between the water and the air above the device. | 10-28-2010 |
Marc Chapdelaine, Wilmington, DE US
| Patent application number | Description | Published |
|---|---|---|
| 20080318925 | Compounds and Uses Thereof - 849 - This invention relates to the use of compounds having the structural formula I below: | 12-25-2008 |
| 20080318943 | Compounds and Uses Thereof - 848 - This invention relates to novel compounds having the structural formula I below: | 12-25-2008 |
| 20100184738 | Uses of cinnoline compounds to treat schizophrenia - This invention relates to the use of compounds having the structural formula I below: | 07-22-2010 |
Marc J. Chapdelaine, Wilmington, DE US
| Patent application number | Description | Published |
|---|---|---|
| 20090018112 | Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula I below: | 01-15-2009 |
| 20090036454 | Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula I below: | 02-05-2009 |
| 20110144331 | Cinnoline Compounds for the Treatment of Anxiety, Cognitive and Mood Disorders - This invention relates to novel compounds having the structural formula I below: | 06-16-2011 |
Pierre Chapdelaine, Saint-Romuald CA
| Patent application number | Description | Published |
|---|---|---|
| 20090088400 | PROSTAGLANDIN E2 MODULATION AND USES THEREOF - Methods, uses, kits and products are described for the prognosis, diagnosis, prevention and treatment of myotronic dystrophy type 1 (DM1), and more particularly for the prognosis, diagnosis, prevention and treatment of the congenital form of myotronic dystrophy type 1 (cDM1), based on changes in/modulation of prostaglandin E | 04-02-2009 |
| 20100304416 | PROSTAGLANDIN E2 MODULATION AND USES THEREOF - Methods, uses, kits and products are described for the prognosis, diagnosis, prevention and treatment of myotronic dystrophy type 1 (DM1), and more particularly for the prognosis, diagnosis, prevention and treatment of the congenital form of myotronic dystrophy type 1 (cDM1), based on changes in/modulation of prostaglandin E | 12-02-2010 |